Juluca 50 mg

Juluca 50 mg tablets contain dolutegravir, an antiretroviral medication used in HIV treatment. This oral tablet is manufactured by ViiV Healthcare ULC in Canada.

Juluca 50 mg tablets are primarily used as part of a combination therapy to manage HIV-1 infection in adults and children weighing at least 40 kg. Dolutegravir, the active ingredient, works by inhibiting the integrase enzyme, which is crucial for the HIV virus to multiply. This helps to reduce the amount of HIV in the body, improving immune function and reducing the risk of HIV-related illnesses. Juluca is often prescribed alongside other antiretroviral drugs to create a comprehensive treatment regimen.

Common effects of Juluca 50 mg tablets may include headache, fatigue, and nausea. Some individuals might experience dizziness, insomnia, or abdominal discomfort. These effects vary among users and are not experienced by everyone. If any effects are severe or persistent, it is important to consult a healthcare provider.

Juluca 50 mg tablets should be handled with care, stored at room temperature, and kept out of reach of children. It is important to follow the prescribed dosage and not to share this medication with others. Regular medical check-ups are recommended to monitor the effectiveness and any potential side effects of the treatment.

Juluca 50 mg tablets may interact with certain medications, including antacids, laxatives, and other drugs that affect liver enzymes. It is important to inform your healthcare provider about all medications you are taking to avoid potential interactions. Alcohol consumption should be moderated, as it may exacerbate some side effects.